Abstract
Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection
Highlights
MethodsSmall intestinal bacterial overgrowth (SIBO) is characterised by a change in the number/type of bacteria within the small intestine and is a common feature of patients who have undergone gastroesophageal reconstruction.[1]
The current study provides valuable new insights for SIBO after surgery for oesophagogastric cancer (OGC)
Patient reported outcomes suggest that the manifestations of SIBO are nonspecific and include a range of symptoms that overlap with other digestive disorders
Summary
Small intestinal bacterial overgrowth (SIBO) is characterised by a change in the number/type of bacteria within the small intestine and is a common feature of patients who have undergone gastroesophageal reconstruction.[1] Symptoms of SIBO are characterised as non-specific and range from bloating to malnutrition. The aim of the current study is to determine the prevalence of SIBO in oesophagogastric cancer (OGC) resected patients and to investigate the impact of this disorder on gastrointestinal (GI) symptoms and HRQoL.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
